This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, P.
Right arrow Articles by Sherry, S
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rogers, P.
Right arrow Articles by Sherry, S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 60, Issue 6 758-762, Copyright © 1978 by Journal of Bone and Joint Surgery, Inc

JOURNAL CONTENTS

Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip

PH Rogers, PN Walsh, VJ Marder, GC Bosak, JW Lachman, WG Ritchie, L Oppenheimer and S Sherry

A randomized, double-blind controlled trial of low-dose heparin combined with sulfinpyrazone to prevent deep-vein thrombosis after operation on the hip was carried out. In a group of seventy-three patients after arthroplasty, postoperative thrombosis of the veins of the lower limbs occurred in 51 per cent of the control patients and in 36 per cent of the treated patients. In a fracture group of thirty patients, thrombosis occurred in 75 per cent of the control patients and in 36 per cent of the treated patients. These differences are of borderline statistical significance in the fracture group and are of no statistical significance in the arthroplasty group. However, a 36 per cent incidence of venous thrombosis in the drug-treated patients is too high to justify recommendation of the regimen tested without careful monitoring of patients by tests designed to detect thrombosis. Then, appropriate anticoagulant therapy can be instituted if necessary.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 338S - 400S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler
Prevention of Venous Thromboembolism
Chest, January 1, 2001; 119(1_suppl): 132S - 175S.
[Full Text] [PDF]

Home page
 JBJSHome page
K. B. Freedman, K. R. Brookenthal, R. H. Fitzgerald, S. Williams, and J. H. Lonner
A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty
J. Bone Joint Surg. Am., July 1, 2000; 82(7): 929 - 929.
[Abstract] [Full Text]

Home page
 JBJSHome page
C. W. FRANCIS, V. D. PELLEGRINI JR., S. TOTTERMAN, A. D. BOYD JR., V. J. MARDER, K. M. LIEBERT, B. N. STULBERG, D. C. AYERS, A. ROSENBERG, C. KESSLER, et al.
Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
J. Bone Joint Surg. Am., September 1, 1997; 79(9): 1365 - 72.
[Abstract] [Full Text]

Home page
 CLIN APPL THROMB HEMOSTHome page
L. Poller, J. M. Thomson, P. K. MacCallum, D. A. Nicholson, F. J. Weighill, and J. G. Lemon
Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity
Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 267 - 273.
[Abstract] [PDF]